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The risk of family history of ischemic heart disease in-
dependent of other well described risk factors has reo
mained difficult to quantitate. Significant coronary ar-
tery disease was determined by coronary arteriography
to be present in 223 patients and absent in 57 control
subjects. Age, sex, blood pressure, serum cholesterol,
cigarette smoking and the presence of diabetes and left
ventricular hypertrophy on the electrocardiogram were
tabulated for each patient and the data used to assign a
risk score based on the American Heart Association mul-
tivariate model. Subjects were stratified and matched
according to risk score to estimate risk of family history
independent of familial aggregation of these seven other
risk factors. Angina, myocardial infarction, cardiac death
and any ischemic heart disease were ascertained in 1,319
first degree relatives. Odds ratios for overall, stratified
Clinical observations as well as published studies (1-14)
have long supported the concept that family history of isch-
emic heart disease is an important consideration in assessing
a patient' s risk of developing coronary artery disease. How-
ever. the relative importance of family history as a risk factor
for coronary artery disease independent of the more estab-
lished risk factors remains controversial. Several investi-
gators, most notably Rissanen and Nikkila (11.12) and
Goldstein et al. (13,14) reported that ischemic heart disease
aggregates in families in which other risk factors such as
hypertension and hypercholesterolemia also aggregate, while
others (9, 10), including the Framingham group (9), reported
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and matched comparisons of these end points in relatives
of patients and control subjects ranged between 2.0 and
3.9 (p < 0.01 for all comparisons), indicating a higher
frequency of all ischemic heart disease end points in
relatives of patients with documented coronary artery
disease.
Life table comparison of patients at lowest risk with
those at higher risk showed significantly greater cu-
mulative frequency and earlier age of onset of all isch-
emic heart disease end points in relatives of low risk
patients. These observations indicate that some of the
risk associated with family history is independent of fa-
milial aggregation of other known risk factors and sug-
gest that the independent effects of family history may
be most important in individuals who otherwise are at
low risk.
a risk attributable to family history that is independent of
the other major risk factors.
Efforts to clarify the role of family history have been
limited by several methodologic problems. Nearly all stud-
res have relied on clinical diagnose s of angina and myo-
cardial infarction to define patients and control subjects,
rather than using angiographic data. Second, the effects of
confounding risk factors, such as diabetes , hypertens ion and
serum cholesterol. have not always been considered (3-6,8),
although it is known that these risk factors are unequally
distributed in the families of patients with and without coro-
nary artery disease 01-14). Finally, even when confound-
ing variables have been considered, the risk associated with
family history has been calcu lated only for the group of
patients with coronary artery disease as a whole (9-12) ,
ignoring the possibility that family history may be of greater
importance in some subsets of patients, such as patients in
whom other risk factors are absent or mild.
Therefore. we designed this study, utilizing diagnostic
data obtained by coronary angiography, to test two hy-
potheses: I) family history of ischemic heart disease is an
independent risk factor for coronary artery disease, and 2)
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family history is of particular importance in patients who
are at low risk as assessed by current risk factor criteria.
Methods
Study group. All 796 patients aged 30 to 60 years who
underwent coronary arteriography in the cardiac catheter-
ization laboratory at Presbyterian Hospital between January
1, 1978 and May 31, 1982 were considered candidates for
the study and were mailed a questionnaire. Fifty-nine ques-
tionnaires were returned because they could not be deliv-
ered, and 373 patients did not respond. The questionnaire
was completed and returned by 364 patients. Of these, 47
were excluded from the analysis because clinical data were
not available, because the patients replied after the analysis
was completed or because they were younger than 30 or
older than 60 years of age at the time of coronary angiog-
raphy. The remaining 317 patients constituted the study
group and provided information about a total of 1,319 first
degree relatives.
Questionnaire. The questionnaire asked for the follow-
ing information about each first degree relative: occurrence
of angina or chest pain during exertion, occurrence of myo-
cardial infarction or heart attack, cause of death, the age of
onset of angina or myocardial infarction and the current age
or the age at death of each relative. Patients were asked to
classify the cause of death of their relatives as sudden (dur-
ing sleep or within 6 hours of having been well) or due to
a heart attack or to some other cause. Any relative described
as dying suddenly or from a heart attack was considered to
have died a cardiac death. Any relative described as having
had angina or a myocardial infarction or as having died a
cardiac death was considered to have had ischemic heart
disease. A first degree relative was defined as a natural
parent, brother or sister and not as an adoptive parent or
step-sibling or half-sibling. A random sample of the re-
spondents was telephoned and the family history was retaken
with the interviewer blind to the respondents' status as a
patient or control subject and to the original responses to
questions about family history. One hundred fifty-eight (83%)
of 191 categoric responses were concordant, and 63 (83%)
of 76 of the ages of relatives were concordant within 2
years.
Coronary arteriography and left ventriculography.
The presence and severity of coronary artery disease in each
proband were established from coronary arteriograms in-
terpreted jointly by a cardiologist and a cardiovascular ra-
diologist. Selective arteriography of the right and left coro-
nary arteries was performed by either the Judkins (15) or
Sones (16) technique. Coronary arteriograms were recorded
on 35 mm cine film from the image displayed on a cesium
iodide image intensifier in 6 inch (15.24 em) mode. Coro-
nary stenoses causing 50% or greater narrowing of the ar-
terial diameter were defined as significant lesions (17,18).
Contrast left ventriculograms were recorded during an in-
jection of 45 ml of contrast material for 3 seconds directly
into the left ventricle.
The diagnosis ofprevious myocardial infarction was es-
tablished by the presence of an appropriate clinical history
together with either Q waves on the electrocardiogram at
rest scored according to the American Heart Association
criteria (19), or localized left ventricular wall motion ab-
normalities documented by ventriculography. Cardiac di-
agnoses and the indication for coronary arteriography were
also recorded for each patient.
On the basis of these data, the study group was divided
into three subgroups: 1) 223 patients with significant coro-
nary artery disease; 2) 57 control subjects without significant
coronary artery disease who underwent coronary arteriog-
raphy for an indication other than the evaluation of chest
pain; and 3) 37 patients without significant coronary artery
disease who underwent cardiac catheterization for evalua-
tion of recurrent chest pain. The latter 37 patients were
carried as a separate category and not included in the control
group because of the possibility that a family history of
ischemic heart disease may have influenced the referral of
these patients for arteriography.
Of the 57 patients in the control group, coronary arte-
riography was performed as part of the evaluation of valvular
heart disease in 45, congestive cardiomyopathy in 8 and
congenital heart disease in 4.
Clinical information (Table 1). From the clinical rec-
ord, the following seven coronary risk factors recognized
by the American Heart Association (20) were determined
for each patient: age, sex, serum cholesterol, cigarette smok-
ing, diabetes, blood pressure and left ventricular hypertro-
phy by electrocardiographic criteria. Age was defined as the
age at the time of cardiac catheterization. Serum cholesterol
was recorded as the cholesterol level measured on the day
of cardiac catheterization or on the day nearest to that day.
For the several patients who underwent cardiac catheteriza-
tion after a lengthy hospitalization and whose cholesterol
level decreased significantly during hospitalization, the serum
cholesterol on the day of admission was recorded. Because
several subjects stopped smoking shortly before the time of
catheterization, cigarette smoking was scored as positive if
the patient was smoking cigarettes at the time of admission
for cardiac catheterization or had a history of smoking of
10 pack-years or more at any time in the past. Neither pipe
nor cigar smoking was counted as positive. Diabetes was
considered to be present if the patient was under treatment
for diabetes with insulin, an oral hypoglycemic agent or a
diabetic diet or was considered by the admitting physician
to be diabetic or if a random blood glucose determination
obtained at the time of admission was 200 mg/dl or greater.
Blood pressure was recorded as the first blood pressure noted
in the chart by a physician at the time of admission for
cardiac catheterization. Left ventricular hypertrophy on the
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T ab le 1. Clinical Characteristics of Patients With Coronary Artery Disease (cases ) and
Control Subjects
Cases Control Subjects p Value
Individuals in study (no) 223 57
Mean age at catheterization (yr) ~ , 49 < 0.01*
Male (%) 89 44 < O.oolt
Blood pressure (mrn Hgl
Mean systolic 132 127 NS*
Mean diastolic 82 75 < 0.001*
Mean serum cholesterol (mg/dl) 240 213 < 0.01*
Diabetes (%) 14 2 < O.Olt
Cigarette smoking (o/r ) 67 44 < O.Olt
LVH on ECG (%) 13 28 < O.Olt
Mean AHA risk score 8.5 3.8 < 0.001*
Parents
No 446 113
Mean years at risk 70 67 < 0.05*
Siblmgs
No. 481 102
Mean years at nsk 54 47 < 0 001*
All relatives
Mean years at risk 62 58 < 0.001*
"Two-tatled I test for mdependent samples; t chi-square test. AHA = American Heart Association; ECG
= electrocardiogram; LVH == left ventricular hypertrophy; no == number of; NS = not significant; p ==
probability.
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admitting electrocardiogram was scored by the Romhilt cri-
teria (21).
011 the basis of these seven coronary risk factors . all
aggregate risk score was assigned to each patient using
multivariate criteria derived from the Framingham study and
publ ished by the American Heart Association (20). This risk
scori ng system predicts the likelihood that an asymptomatic
patient will develop symptomatic ischemic heart disease
over the next 6 years.
The American Heart Association risk tables (20) are based
on serum cholesterol as determined by the Abell-Kendall
method (22), whereas at Presbyterian Hospital between 1978
and 1982 serum cholesterol was measured by several sue-
cessive autoanalyzer methods. For each of these autoana-
lyzer methods. the variance between the Presbyterian Hos-
pital and Abell-Kendall methods is smaller than the range
of error for the measurement , with the largest variance be-
tween the two methods being on the order of 5 mg/dl over
the range of 185 to 335 mg/dJ. Because of the close com-
parability of the methods, these small differences were ig-
nored in calculating the aggregate risk score.
Dataanalysis. Ten patients could not be assigned a risk
score because no serum cholesterol determination was avail-
able . Seven of these were subjects with significant coronary
artery disease and three were control subjects. These 10
patients and their 40 first degree relatives were included in
the overall comparison of patients and control subjects but
not in analyses in which patient s were classified or matched
by risk score.
Subjects with significant coron ary artery disease had sub-
stantially higher mean risk scores than did control subjects
as assessed by the seven factor Framingham model (Table
I) . To account for the possibilit y that the association of
family history with coronary artery disease was a result of
aggregation of coronary disease and these seven other risk
factors in the same familie s. we performed stratified and
matched analyses. The 2 16 patients with significant coro-
nary artery disease and 54 control subjects who were as-
signed risk scores were classified into four groups of nearly
equal size based on the seven factor coronary risk scores
(Table 2). Since control subjects tended to have lower risk
scores , 33 (62%) of 54 subjects had risk scores in the same
Table 2. Stratification of Patients With Coron ary Artery Disease (cases ) and Co ntrol Subjects
No uf No. of No. of No. of
Group Risk Score Cases Case Relatives Control Subject, Cuntrol Relatives
I 0.4 to 4.1 55 240 33 128
II 4 3 to 7 0 55 223 14 45
111 7.1 to 10.8 53 223 4 19
IV 11.1 to 41.0 53 212 3 12
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range as the 25% of the patients with coronary artery disease
placed in group I, the lowest risk group, and only 21 control
subjects had risk scores in the range of the patients in groups
II, III and IV. Stratified analysis was performed by com-
paring patients with significant coronary artery disease with
control subjects with similar aggregate risk scores. Because
the number of control subjects in groups II, III and IV was
too small to permit meaningful comparison with patients
with significant coronary artery disease in these risk groups,
stratified analysis was confined to data from patients in
group I.
Because the mean risk score of the patients with coronary
disease in group I was slightly higher than the mean score
of the control subjects in the same stratum (2.6 for patients,
1.6 for control subjects [p<O.OOl), analysis by two-sided
t test), we also performed a matched analysis. One patient
with significant coronary artery disease was matched to one
control subject. The patient with the risk score most nearly
identical to that of the score of the control subject was
selected as the match, and all risk scores were matched
within 1.0 point. Forty-five pairs were created in this way;
there were too few patients with low risk scores to match
each control subject. Because the number of relatives for
each patient and control subject in the matched pairs was
not necessarily equal, end points in relatives were compared
as in an unmatched analysis.
Statistical analysis. Life table analysis was performed
using the Statistical Package for the Social Sciences (23,24).
Odds ratios were calculated with 95% confidence intervals,
where a lower limit of 1.0 or greater is equivalent to a
probability value of 0.05 or less based on the chi-square
test for a two by two table. Life tables were compared by
means of the Lee-Desu statistic (25) and its associated prob-
ability value, which describe the likelihood that the survival
(or end point) distributions of two groups differ by chance.
The study was approved by the Institutional Review Board
of the College of Physicians and Surgeons of Columbia
University.
Results
Overall analysis. Odds ratios comparing the incidence
of the four cardiac end points for relatives of patients with
significant coronary artery disease with that in relatives of
control subjects (Table 3) ranged between 2.1 and 3.0 and
were highly significant statistically, indicating that angina,
myocardial infarction, cardiac death and ischemic heart dis-
ease were more frequent among relatives of patients than
of control subjects.
Stratified analysis. Comparison of the incidence of all
four end points in relatives of patients in group I with the
incidence in relatives of control subjects of comparable risk
yielded odds ratios between 2.5 and 3.9 (Table 3). All four
of these odds ratios were highly significant statistically, and
tended to be larger than the odds ratios produced by the
unstratified analysis. The matched analysis (Table 4) showed
odds ratios between 2.0 and 3.0 for these end points, con-
firming the results of the overall and stratified analyses.
Subset of patients with prior myocardial infarction.
Because of the possibility that some subjects with significant
coronary artery disease may have been referred for arteri-
ography partly because of a strong family history of ischemic
heart disease, we compared the family histories of the 34
patients in group I who had had myocardial infarction before
the time of coronary arteriography, a group in which such
referral bias is unlikely, with the family histories of control
Table 3. Comparisons of Relatives of Patients With Coronary Artery Disease (cases) and Control Subjects
No. of Case Relatives No. of Control Relatives Odds Ratios (95% confidence interval) p Value
Comparison of Relatives of All Cases With Relatives of All Control Subjects
Angina
Myocardial infarction
Cardiac death
Ischemic heart disease
135 of 729
173 of 811
134 of 904
249 of 802
13 of 185
17 of 192
16 of 211
33 of 185
3.0 (1.7 to 5.3)*
2.8 (1.7 to 4.6)
2.1 (1.3 to 3.6)
2.1 (1.4 to 3.1)
<0.001
<0.0001
<0.01
<0.001
Comparison of Relatives of Cases in Group I With Relatives of Control Subjects in Group I
Angina
Myocardial infarction
Cardiac death
Ischemic heart disease
37 of 190
53 of 216
32 of 238
69 of 213
9 of 110
9 of 116
6 of 126
18 of 110
2.7 (1.3 to 5.7)
3.9 (1.9 to 7.9)
3.1 (1.3 to 7.4)
2.5 (1.4 to 4.3)
<0.01
<0.001
<0.01
<0.01
Companson of Relatives of Cases In Group I With Prior Myocardial InfarctionWith Relattves of Control Subjects In Group I
Angina
Myocardial infarction
Cardiac death
Ischemic heart disease
24 of 129
33 of 145
22 of 158
45 of 144
9 of 110
9 of 116
6 of 126
180fllO
2.6 (1.2 to 5.7)
3.5 (1.7 to 7.4)
3.2 (1.3 to 7.9)
2.3 (1.3 to 4.3)
<0.05
<0.01
<0.05
<0.01
The groups in these comparisons are not mutually exclusive. *95% confidence intervals in parentheses.
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Table 4. Matched Comparison of Patients With Coronary Disease (cases) and Control Subjects
No, of Case Relatives No of Control Relatives Odds Ratios (95% confidence interval) p Value
Angm. 33 of 188 II of 167 3,0 (1,5 to 6.0) <0.01
Myocardial infarction 47 of 209 15 of 171 3.0 (1.6 to 5 5) <0,001
Cardiac death 30 of 222 14 of 189 2.0 (1.0 to 3.8) <0,01
Ischen IC heart disease 63 of 209 30 of 166 2.0 (1,2 to 3.2) <0,01
subjects in group L The odds ratios produced by this analysis
are between 2,3 and 3.5 for the four end points and are all
statistically significant (Table 3).
Life table analysis. Life table analysis was performed
to account for differences in age between two groups of
relatives, which may be important when one group is sig-
nificantly older and has had longer to develop end points,
and to examine differences in age at which relatives de-
veloped end points. The mean age at death or at the time
of the questionnaire, which represents years at risk for oc-
currence of end points, was somewhat greater for relatives
of patients in group I than for relatives of control subjects
in group L The mean age of parents of patients in group I
was 68.3 years compared with 65.8 years for parents of
control subjects in group I (p > 0.1, analysis by two-sided
t test I, whereas the mean age of siblings of patients in group
I was 47.7 years compared with 43.8 years for siblings of
control subjects in this group (p < 0.05).
figure 1 shows the life table comparison of relatives of
patients with coronary disease in group I with relatives of
control subjects of comparable risk for the end points of
myocardial infarction and any ischemic heart disease. Both
comparisons are highly significant statistically, In the age
range of 50 to 65 years, the cumulative probability of myo-
cardial infarction is four- to sixfold greater in relatives of
patients than in relatives of control subjects, The cumulative
probability of any ischemic heart disease in this age range
is three- to fivefold greater. Life table analysis also showed
greater cumulative frequency of angina (p < 0.05) and
cardiac death (p < 0.05) in relatives of patients in group I
compared with relatives of control subjects in this group.
Low risk versus high risk patients. To examine whether
family history was of greater importance in patients with
coronary disease at low risk than in patients at higher risk
as assessed by the seven factor risk score, we calculated
odds ratios for the occurrence of end points in relatives of
patients in group I (at lowest risk) compared with relatives
of patients in combined groups II, III and IV, These odds
Figure 1. Life table comparison showing increased frequency and
earlier age of onset of myocardial infarction (A) and of ischemic
heart disease (B) in relatives of patients with coronary artery dis-
ease (cases) in group I compared with relatives of control subjects
(controls) in group L
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ratios showed a similar incidence of end points in relatives
of patien ts in the two groups . None of these comparisons
showed a statistically significant difference.
These two groups of relatives, however, differed signif-
icantly in years at risk. The mean age of parents of low risk
patients was 68 .3 years compared with 71.0 years for parents
of high risk patients (p < 0. 1, analysis by two-sided t test);
the mean age of siblings of low risk patients was 47.7 years
compared with 56.2 years for siblings of high risk patients
(p < 0.00 1).
Because these differences in age may have caused an
underestimation of the true difference between these two
groups of relatives when analyzed by using uncorrected odds
ratios, we also compared the relatives of low and high risk
patients by means of life tables. The results of the life table
analysis for myocardial infarction and ischemic heart disease
(Fig . 2) indicate that these two groups have different dis-
tributions of both these end points, with both a higher in-
cidence and earlier age of incidence in the relatives of pa-
tients in the low risk group. Both comparisons are highly
significant stat istically. For both end points, the differe nce
is greatest for relatives between the ages of 50 and 60 years,
with a twofo ld greate r cumulat ive probabi lity of myocardial
infarctio n and a one and one-halffold greater cumulative
probability of ischemic heart disease in the relatives of low
Figure 2. Life table comparison showing increased frequency and
earlie r age of onset of myocardial infarction (A) and of ischemic
heart disease (B) in relatives of patients with coronary artery dis-
ease (cases) in group I compared with relatives of patients in groups
II, III and IV.
risk patients . Life table analysis also showed greater cu-
mulative frequency of angina (p < 0. 1) and cardiac dea th
(p < 0.05) in relatives of low risk patients compared with
those of higher risk patient s.
Patien ts with chest pain. The 37 pat ients who under-
went arteriography becau se of recurrent chest pain and were
found to have normal coronary arteries had a mean risk
score of 4 .9 compared with 8.5 for patients with significant
coronary artery disease and 3.8 for control subjects . The
mean age at arteriograp hy in the group with recurrent chest
pain was 51.2 years compared with 53.3 years for patients
with significant coronary artery disease and 48. 9 years for
control subjects. Although more nearly resembling the con-
trol subjects with respect to risk score , the group with chest
pain more closely resembl ed the group with coronary artery
disease with respect to fami ly history of heart disease . Com -
parison of relatives of patients with ches t pain in group I
with relatives of patients in group I showed no statis tically
significant differe nces , with a probability value greater than
0.1 (chi-sq uare test) for the odds ratios and a probability
value greater than 0.05 for the life tables for eac h of the
four end points .
Discussion
Family history as an independent r isk factor .
Extensive work by other investigators (26,27) has estab-
lished age, sex, cigarette smoking, diabetes, serum choles-
terol, blood pressure and left ventricular hypertrophy on the
electrocardiogram as major risk factors for coronary artery
disease. Our study suggests that family history of ischemic
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heart disease is also a significant independent risk factor.
The independent importance of family history is suggested
by the overall comparison of patients with significant coro-
nary artery disease and control subjects as well as by com-
parisons in which all subjects were stratified and matched
according to aggregate risk based on these seven other risk
factors. These comparisons indicated that angina, myo-
cardial infarction, cardiac death and the summary end point
of any ischemic heart disease was two to three times as
frequent among relatives of patients with significant coro-
nary artery disease as among relatives of control subjects.
In addition to the higher incidence of these end points,
relatives of patients had an earlier age of onset of these end
points, as shown in the life tables. The cumulative proba-
bility of myocardial infarction in patients' relatives in the
age range 50 to 65 years was four to six times as great as
for the control subjects' relatives, and the cumulative prob-
ability of any ischemic heart disease was three to five times
as great.
Our second finding is that relatives of patients with sig-
nificant coronary artery disease who are at low risk, as
assessed by the seven established major risk factors, have
a higher incidence and earlier age of onset of ischemic heart
disease than do relatives of patients with significant coronary
artery disease who are at higher risk. The cumulative prob-
ability of myocardial infarction in a relative in the age range
50 to 60 years was twice as great for patients in the lowest
quartile of risk as for patients in the upper three quartiles.
The risk of any ischemic heart disease was one and one-
halt times as great. This second finding may help to account
for the unexplained risk of coronary artery disease in youn-
ger patients who have few of the conventional risk factors
(28 -31). It suggests the possibility that susceptibility to
coronary artery disease aggregates in families in the absence
of elevated levels of other coronary risk factors.
Potential sources of bias. Our design is well protected
against misclassification of patients and control subjects be-
cause the diagnostic criterion was arteriographic demon-
stration of coronary artery disease, currently accepted as the
most accurate method of diagnosis (32). The classification
was carried out by investigators who did not know the pa-
tients' family history and before such history was ascertained.
Use of coronary arteriography to select patients skews
our series toward greater severity of disease. This skewing
is unlikely to bias the observed association of ischemic heart
disease with family history, but it may restrict the gener-
alizations that may be drawn from it to patients with more
severe disease.
Choice of appropriate control subjects for this series re-
qu rres subjects with similar opportunity for detection of
disease through cardiac catheterization, In addition, com-
parability with respect to risk factors other than family his-
tory is desirable. To achieve a degree of comparability, we
stratified patients and control subjects according to an ag-
gregate risk score based on seven individual risk factors.
This approach is imperfect in that each group may have
similar aggregate risk scores while having significantly dif-
ferent levels of individual risk factors. Some values assigned
for the individual risk factors may not have been represen-
tative of an individual's clinical history, because some of
the blood pressure measurements were in individuals who
had a prior myocardial infarction or were being treated with
antihypertensive agents. We attempted to assign the most
representative cholesterol value by using the value on the
day of admission and to classify cigarette smoking based
on significant past history as well as present smoking status.
Potential sources of misclassification. Misclassi-
fication of the exposure (family history) may have arisen in
several ways. First, the respondent may not know the facts
about the relative, reporting fewer or more than the true
number of affected relatives or an incorrect age for onset
of disease. When this type of error arises independently of
the respondent's status as patient or control subject, the
effect will usually be to cause an underestimation of the
true difference between the two. No corroboration of family
history was obtained from case records, but other investi-
gators (33,34) who have sought independent corroboration
of questionnaire responses to inquiries about family history
of ischemic heart disease have reported correlations in the
range of 70 to 80%.
Second, patients with significant coronary artery disease
may preferentially recall or report diseased family members
compared with nondiseased family members or compared
with recall and reporting by control subjects. These effects
could lead to an overestimation of the odds ratios for the
comparisons of patients and control subjects. Preferential
reporting, however, is unlikely to have affected the com-
parison between low and high risk patients.
Third, because control subjects were younger than pa-
tients with coronary disease and low risk patients were youn-
ger than higher risk patients, their relatives were also youn-
ger and so had fewer years at risk for development of ischemic
heart disease. As noted earlier, this effect would cause an
underestimation of the odds ratios for these comparisons.
The life table analysis effectively eliminates this source of
error by using age of onset of disease as the numerator and
years at risk as the denominator of the comparison.
The loss of information on nonrespondents may have
biased our findings, but only in the event that nonrespondent
patients with coronary disease had a weak family history,
nonrespondent control subjects had a strong family history,
or both. This possibility remains a source of uncertainty.
Finally, there may be bias in the selection or referral of
patients for arteriography. Individuals with a strong family
history of ischemic heart disease may bring themselves to
the attention of physicians sooner than those without, and
physicians may refer such patients for arteriography more
readily. Although this process is unlikely to bias compari-
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sons between low and high risk patients with coronary dis-
ease, it could bias patient-control subject comparisons. We
attempted to protect our study against this possibility by
analyzing the subset of patients with myocardial infarction
documented before referral for arteriography. In such pa-
tients, the purpose of arteriography is nearly always eval-
uation for surgery, not diagnosis of coronary artery disease.
The analysis of this subgroup, which is less likely to have
been biased by selection or referral bias, supported the find-
ings of the overall comparisons.
Patients with chest pain, Referral bias may have influ-
enced the selection of patients without significant coronary
disease whose indication for arteriography was recurrent
chest pain. This group, which had a low overall risk profile
based on the seven classic risk factors, had relatives with a
high incidence of ischemic heart disease, significantly higher
than relatives of control subjects and comparable with rel-
atives of patients with significant coronary artery disease
with similar risk scores. Although this finding may reflect
a clinical reality, the possibility of referral bias makes this
group unsuitable as control subjects, and these patients were
excluded from the patient-control subject comparisons.
Control subjects included only patients undergoing cardiac
catheterization for evaluation of valvular heart disease, car-
diomyopathy or congenital heart disease.
In three previous studies (35-37) of the role of family
history in ischemic heart disease, coronary arteriography
was used to define patients and control subjects. In each of
these studies, the control group included patients with re-
current chest pain and normal coronary arteriograms. All
three studies reported relatively weak associations between
angiographically demonstrated coronary artery disease and
family history of ischemic heart disease. The modest role
for family history reported in these studies could be ex-
plained by referral bias in the control SUbjects.
Conclusions. This study suggests that family history for
ischemic heart disease is a significant and independent risk
factor for coronary artery disease. In our study group, family
history was most prominent in those patients with coronary
disease with the lowest overall cardiovascular risk profile,
suggesting the possibility that in this group there is familial
aggregation of a lower threshold for developing clinically
apparent disease.
We thank Lee Goldman, MD for his helpful reading of the manuscript.
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